Uranium Royalty (UROY) Competitors $1.78 -0.25 (-12.32%) Closing price 03/3/2025 04:00 PM EasternExtended Trading$1.81 +0.03 (+1.69%) As of 03/3/2025 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends UROY vs. CSR, SBR, NXRT, PGRE, AAMI, GETY, ORC, AC, BRSP, and SITCShould you be buying Uranium Royalty stock or one of its competitors? The main competitors of Uranium Royalty include Centerspace (CSR), Sabine Royalty Trust (SBR), NexPoint Residential Trust (NXRT), Paramount Group (PGRE), Acadian Asset Management (AAMI), Getty Images (GETY), Orchid Island Capital (ORC), Associated Capital Group (AC), BrightSpire Capital (BRSP), and SITE Centers (SITC). These companies are all part of the "trading" industry. Uranium Royalty vs. Centerspace Sabine Royalty Trust NexPoint Residential Trust Paramount Group Acadian Asset Management Getty Images Orchid Island Capital Associated Capital Group BrightSpire Capital SITE Centers Centerspace (NYSE:CSR) and Uranium Royalty (NASDAQ:UROY) are both small-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, community ranking, earnings, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership. Is CSR or UROY more profitable? Uranium Royalty has a net margin of 0.00% compared to Centerspace's net margin of -4.34%. Uranium Royalty's return on equity of 1.79% beat Centerspace's return on equity.Company Net Margins Return on Equity Return on Assets Centerspace-4.34% -1.34% -0.60% Uranium Royalty N/A 1.79%1.75% Do analysts recommend CSR or UROY? Centerspace currently has a consensus price target of $74.43, suggesting a potential upside of 12.86%. Uranium Royalty has a consensus price target of $5.60, suggesting a potential upside of 214.61%. Given Uranium Royalty's stronger consensus rating and higher possible upside, analysts plainly believe Uranium Royalty is more favorable than Centerspace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Centerspace 0 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.43Uranium Royalty 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00 Does the MarketBeat Community favor CSR or UROY? Centerspace received 15 more outperform votes than Uranium Royalty when rated by MarketBeat users. However, 90.48% of users gave Uranium Royalty an outperform vote while only 43.59% of users gave Centerspace an outperform vote. CompanyUnderperformOutperformCenterspaceOutperform Votes3443.59% Underperform Votes4456.41% Uranium RoyaltyOutperform Votes1990.48% Underperform Votes29.52% Do institutionals and insiders believe in CSR or UROY? 79.0% of Centerspace shares are owned by institutional investors. Comparatively, 24.2% of Uranium Royalty shares are owned by institutional investors. 0.9% of Centerspace shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has better earnings and valuation, CSR or UROY? Centerspace has higher revenue and earnings than Uranium Royalty. Centerspace is trading at a lower price-to-earnings ratio than Uranium Royalty, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCenterspace$260.98M4.23$41.97M-$1.27-51.93Uranium Royalty$38.29M6.21$7.24M$0.0359.33 Does the media favor CSR or UROY? In the previous week, Centerspace had 3 more articles in the media than Uranium Royalty. MarketBeat recorded 6 mentions for Centerspace and 3 mentions for Uranium Royalty. Uranium Royalty's average media sentiment score of 1.70 beat Centerspace's score of 1.42 indicating that Uranium Royalty is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Centerspace 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Uranium Royalty 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has more risk and volatility, CSR or UROY? Centerspace has a beta of 0.9, indicating that its share price is 10% less volatile than the S&P 500. Comparatively, Uranium Royalty has a beta of 1.14, indicating that its share price is 14% more volatile than the S&P 500. SummaryUranium Royalty beats Centerspace on 12 of the 19 factors compared between the two stocks. Get Uranium Royalty News Delivered to You Automatically Sign up to receive the latest news and ratings for UROY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UROY vs. The Competition Export to ExcelMetricUranium RoyaltyCommodity contracts brokers, dealers IndustryEnergy SectorNASDAQ ExchangeMarket Cap$237.79M$19.99B$8.72B$8.39BDividend YieldN/A5.07%11.76%3.98%P/E Ratio59.3517.4212.4419.21Price / Sales6.216.21276.38110.22Price / Cash37.5321.5911.8834.58Price / Book1.051.083.664.28Net Income$7.24M$1.63B$810.14M$247.04M7 Day Performance-14.83%-4.20%-5.21%-4.36%1 Month Performance-23.28%-3.72%-7.17%-5.60%1 Year Performance-32.83%7.63%-0.80%3.38% Uranium Royalty Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UROYUranium Royalty1.7927 of 5 stars$1.78-12.3%$5.60+214.6%-32.8%$237.79M$38.29M59.3510Positive NewsHigh Trading VolumeCSRCenterspace3.0403 of 5 stars$64.48+0.6%$74.43+15.4%+17.8%$1.08B$260.98M-50.77470Positive NewsSBRSabine Royalty Trust2.1679 of 5 stars$68.97-0.2%N/A+5.7%$1.01B$97.23M10.632,020Earnings ReportPositive NewsNXRTNexPoint Residential Trust4.305 of 5 stars$39.03+0.7%$49.00+25.6%+43.4%$991.39M$264.80M22.303Dividend AnnouncementAnalyst DowngradePGREParamount Group2.4926 of 5 stars$4.51-0.3%$4.50-0.1%-1.8%$979.92M$763.66M-4.60330Earnings ReportAAMIAcadian Asset Management2.0696 of 5 stars$24.95-3.0%$27.00+8.2%N/A$931.08M$505.60M11.14350GETYGetty Images3.8857 of 5 stars$2.21-5.4%$5.61+154.5%-56.8%$906.43M$916.55M18.381,700Short Interest ↓Gap UpORCOrchid Island Capital4.6321 of 5 stars$8.84-1.0%$9.50+7.5%-2.5%$824.25M$54.41M14.732,018Short Interest ↓ACAssociated Capital Group2.6313 of 5 stars$37.56-1.3%N/A+11.3%$797.66M$88.18M18.1420Short Interest ↑High Trading VolumeBRSPBrightSpire Capital2.2042 of 5 stars$6.08+0.4%$7.45+22.6%-10.6%$787.81M$244.77M-5.7950Short Interest ↓SITCSITE Centers3.2175 of 5 stars$14.620.0%$35.75+144.6%-93.8%$766.26M$539.46M1.07270Earnings Report Related Companies and Tools Related Companies Centerspace Competitors Sabine Royalty Trust Competitors NexPoint Residential Trust Competitors Paramount Group Competitors Acadian Asset Management Competitors Getty Images Competitors Orchid Island Capital Competitors Associated Capital Group Competitors BrightSpire Capital Competitors SITE Centers Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:UROY) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredLeaked Trump video exposes his secret stocksTen investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the polici...Porter & Company | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Uranium Royalty Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Uranium Royalty With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.